Recent summary of changes to the LAM
The tables below show a summary of changes to the list of approved medicines (LAM) since it was last published. The LAM is published monthly or more frequently if required.
Additions
| Riboflavin (SAS) Intraocular solution (VibexRapid) 0.1% 1.5mL |
| Riboflavin (SAS) eye solution (Trans-epithelial kit) - (Paracel - Vibextra, 2-syringe procedure) 0.25% 2mL |
| Pentoxifylline modified release tablet 400mg |
| d-alpha-tocopherol (vitamin E) capsule 335mg (500 units) |
| Patiromer powder for oral liquid 16.8 g, sachet |
| Dabrafenib dispersible tablet 10mg |
| Trametinib powder for oral solution 50 microgram/mL |
Amendments
| Ezetimibe tablet 10mg |
| Leuprorelin modified release injection 22.5mg intramuscular depot |
| Leuprorelin modified release injection 45 mg subcutaneous depot |
| Testosterone enantate Injection 250 mg/mL |
Deletions
